Elkhorn Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,650
| Closed | -$388K | – | 48 |
|
|
2024
Q2 | $388K | Buy |
5,650
+4,700
| +495% | +$323K | 0.27% | 18 |
|
|
2024
Q1 | $70K | Buy |
950
+600
| +171% | +$44.2K | 0.05% | 33 |
|
|
2023
Q4 | $28K | Sell |
350
-550
| -61% | -$44K | 0.02% | 42 |
|
|
2023
Q3 | $67K | Buy |
+900
| New | +$67K | 0.04% | 36 |
|
|
2022
Q2 | – | Sell |
-1,025
| Closed | -$61K | – | 50 |
|
|
2022
Q1 | $61K | Buy |
+1,025
| New | +$61K | 0.03% | 30 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$34K | – | 45 |
|
|
2021
Q2 | $34K | Hold |
500
| – | – | 0.02% | 33 |
|
|
2021
Q1 | $32K | Hold |
500
| – | – | 0.02% | 35 |
|
|
2020
Q4 | $29K | Buy |
+500
| New | +$29K | 0.02% | 29 |
|
|
2020
Q2 | – | Sell |
-125
| Closed | -$9K | – | 40 |
|
|
2020
Q1 | $9K | Sell |
125
-3,775
| -97% | -$272K | 0.01% | 38 |
|
|
2019
Q4 | $253K | Buy |
3,900
+400
| +11% | +$25.9K | 0.15% | 29 |
|
|
2019
Q3 | $222K | Hold |
3,500
| – | – | 0.13% | 29 |
|
|
2019
Q2 | $236K | Buy |
+3,500
| New | +$236K | 0.14% | 26 |
|
|
2018
Q3 | – | Sell |
-3,800
| Closed | -$269K | – | 31 |
|
|
2018
Q2 | $269K | Buy |
+3,800
| New | +$269K | 0.16% | 25 |
|
|
2017
Q3 | – | Sell |
-3,000
| Closed | -$212K | – | 40 |
|
|
2017
Q2 | $212K | Buy |
+3,000
| New | +$212K | 0.13% | 35 |
|